Annual Total Long Term Liabilities
$215.78 M
-$59.98 M-21.75%
31 December 2023
Summary:
Nektar Therapeutics annual total long term liabilities is currently $215.78 million, with the most recent change of -$59.98 million (-21.75%) on 31 December 2023. During the last 3 years, it has fallen by -$129.92 million (-37.58%). NKTR annual total long term liabilities is now -53.31% below its all-time high of $462.15 million, reached on 31 December 2005.NKTR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$191.50 M
-$14.82 M-7.18%
30 September 2024
Summary:
Nektar Therapeutics quarterly total long term liabilities is currently $191.50 million, with the most recent change of -$14.82 million (-7.18%) on 30 September 2024. Over the past year, it has dropped by -$39.27 million (-17.02%). NKTR quarterly long term liabilities is now -59.62% below its all-time high of $474.23 million, reached on 30 September 2019.NKTR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.8% | -17.0% |
3 y3 years | -37.6% | -43.0% |
5 y5 years | -38.5% | -59.6% |
NKTR Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -38.8% | at low | -45.7% | at low |
5 y | 5 years | -38.8% | at low | -59.6% | at low |
alltime | all time | -53.3% | >+9999.0% | -59.6% | >+9999.0% |
Nektar Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $191.50 M(-7.2%) |
June 2024 | - | $206.32 M(-4.9%) |
Mar 2024 | - | $216.90 M(+0.5%) |
Dec 2023 | $215.78 M(-21.8%) | $215.78 M(-6.5%) |
Sept 2023 | - | $230.76 M(-6.4%) |
June 2023 | - | $246.63 M(-5.5%) |
Mar 2023 | - | $261.00 M(-5.4%) |
Dec 2022 | $275.76 M(-21.8%) | $275.76 M(-3.2%) |
Sept 2022 | - | $284.79 M(-4.5%) |
June 2022 | - | $298.27 M(-4.1%) |
Mar 2022 | - | $310.95 M(-11.8%) |
Dec 2021 | $352.48 M(+2.0%) | $352.48 M(+5.0%) |
Sept 2021 | - | $335.73 M(+0.1%) |
June 2021 | - | $335.35 M(-0.9%) |
Mar 2021 | - | $338.42 M(-2.1%) |
Dec 2020 | $345.69 M(+58.5%) | $345.69 M(+63.7%) |
Sept 2020 | - | $211.19 M(-1.6%) |
June 2020 | - | $214.68 M(+0.3%) |
Mar 2020 | - | $214.04 M(-1.9%) |
Dec 2019 | $218.07 M(-37.8%) | $218.07 M(-54.0%) |
Sept 2019 | - | $474.23 M(+10.5%) |
June 2019 | - | $429.13 M(-1.0%) |
Mar 2019 | - | $433.25 M(+23.6%) |
Dec 2018 | $350.60 M(-3.9%) | $350.60 M(-0.1%) |
Sept 2018 | - | $350.89 M(-1.4%) |
June 2018 | - | $355.78 M(-0.6%) |
Mar 2018 | - | $357.81 M(-1.9%) |
Dec 2017 | $364.88 M(-10.7%) | $364.88 M(-10.0%) |
Sept 2017 | - | $405.35 M(+1.4%) |
June 2017 | - | $399.86 M(-1.3%) |
Mar 2017 | - | $405.22 M(-0.8%) |
Dec 2016 | $408.52 M(-5.2%) | $408.52 M(-1.9%) |
Sept 2016 | - | $416.64 M(-1.5%) |
June 2016 | - | $423.07 M(-0.7%) |
Mar 2016 | - | $426.21 M(-1.1%) |
Dec 2015 | $430.97 M(+26.3%) | $430.97 M(+113.2%) |
Sept 2015 | - | $202.09 M(-40.6%) |
June 2015 | - | $340.49 M(-1.7%) |
Mar 2015 | - | $346.46 M(+1.5%) |
Dec 2014 | $341.24 M(-19.9%) | $341.24 M(-2.3%) |
Sept 2014 | - | $349.13 M(-18.6%) |
June 2014 | - | $429.14 M(+2.8%) |
Mar 2014 | - | $417.51 M(-2.0%) |
Dec 2013 | $426.21 M(+14.5%) | $426.21 M(+21.0%) |
Sept 2013 | - | $352.37 M(-2.9%) |
June 2013 | - | $363.08 M(-1.1%) |
Mar 2013 | - | $367.30 M(-1.3%) |
Dec 2012 | $372.24 M(+179.4%) | $372.24 M(-1.2%) |
Sept 2012 | - | $376.65 M(+45.3%) |
June 2012 | - | $259.30 M(-0.9%) |
Mar 2012 | - | $261.55 M(+96.3%) |
Dec 2011 | $133.21 M(-63.6%) | $133.21 M(-3.7%) |
Sept 2011 | - | $138.25 M(-61.4%) |
June 2011 | - | $358.30 M(-1.7%) |
Mar 2011 | - | $364.36 M(-0.6%) |
Dec 2010 | $366.45 M(+14.5%) | $366.45 M(+17.9%) |
Sept 2010 | - | $310.70 M(-0.9%) |
June 2010 | - | $313.64 M(-1.4%) |
Mar 2010 | - | $318.11 M(-0.6%) |
Dec 2009 | $320.13 M | $320.13 M(+7.7%) |
Sept 2009 | - | $297.19 M(+0.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2009 | - | $297.08 M(-1.0%) |
Mar 2009 | - | $300.03 M(-0.7%) |
Dec 2008 | $302.01 M(-26.8%) | $302.01 M(-26.6%) |
Sept 2008 | - | $411.20 M(+1.0%) |
June 2008 | - | $407.03 M(-0.8%) |
Mar 2008 | - | $410.43 M(-0.5%) |
Dec 2007 | $412.57 M(+9.8%) | $412.57 M(+0.5%) |
Sept 2007 | - | $410.70 M(+4.4%) |
June 2007 | - | $393.46 M(+0.5%) |
Mar 2007 | - | $391.64 M(+4.2%) |
Dec 2006 | $375.80 M(-18.7%) | $375.80 M(-15.2%) |
Sept 2006 | - | $443.01 M(-0.9%) |
June 2006 | - | $447.05 M(+5.3%) |
Mar 2006 | - | $424.43 M(-8.2%) |
Dec 2005 | $462.15 M(+108.2%) | $462.15 M(-0.6%) |
Sept 2005 | - | $464.98 M(+113.1%) |
June 2005 | - | $218.19 M(-0.2%) |
Mar 2005 | - | $218.69 M(-1.5%) |
Dec 2004 | $221.93 M(-45.3%) | $221.93 M(-0.3%) |
Sept 2004 | - | $222.51 M(+1.9%) |
June 2004 | - | $218.32 M(-3.7%) |
Mar 2004 | - | $226.66 M(-44.1%) |
Dec 2003 | $405.74 M(+20.7%) | $405.74 M(-4.7%) |
Sept 2003 | - | $425.53 M(+2.6%) |
June 2003 | - | $414.93 M(+23.7%) |
Mar 2003 | - | $335.49 M(-0.2%) |
Dec 2002 | $336.20 M(-0.5%) | $336.20 M(-0.8%) |
Sept 2002 | - | $338.98 M(+0.6%) |
June 2002 | - | $337.00 M(-0.0%) |
Mar 2002 | - | $337.16 M(-0.2%) |
Dec 2001 | $337.73 M(+5.1%) | $337.73 M(-0.1%) |
Sept 2001 | - | $338.19 M(+0.9%) |
June 2001 | - | $335.12 M(+2.4%) |
Mar 2001 | - | $327.14 M(+1.8%) |
Dec 2000 | $321.45 M(+179.3%) | $321.45 M(+31.4%) |
Sept 2000 | - | $244.64 M(+0.0%) |
June 2000 | - | $244.57 M(-0.8%) |
Mar 2000 | - | $246.47 M(+114.1%) |
Dec 1999 | $115.10 M(+1864.5%) | $115.10 M(+1757.6%) |
Sept 1999 | - | $6.20 M(+3.7%) |
June 1999 | - | $5.97 M(+1.0%) |
Mar 1999 | - | $5.91 M(+0.9%) |
Dec 1998 | $5.86 M(+5.5%) | $5.86 M(+0.9%) |
Sept 1998 | - | $5.81 M(+0.9%) |
June 1998 | - | $5.75 M(+0.9%) |
Mar 1998 | - | $5.70 M(+2.6%) |
Dec 1997 | $5.55 M(+2677.5%) | $5.55 M(+1331.7%) |
Sept 1997 | - | $388.00 K(+139.5%) |
June 1997 | - | $162.00 K(-7.4%) |
Mar 1997 | - | $175.00 K(-12.5%) |
Dec 1996 | $200.00 K(-33.3%) | $200.00 K(0.0%) |
Sept 1996 | - | $200.00 K(0.0%) |
June 1996 | - | $200.00 K(-50.0%) |
Mar 1996 | - | $400.00 K(+33.3%) |
Dec 1995 | $300.00 K(-25.0%) | $300.00 K(+50.0%) |
Sept 1995 | - | $200.00 K(-33.3%) |
June 1995 | - | $300.00 K(-50.0%) |
Mar 1995 | - | $600.00 K(+50.0%) |
Dec 1994 | $400.00 K | $400.00 K(-20.0%) |
Sept 1994 | - | $500.00 K(0.0%) |
June 1994 | - | $500.00 K(-16.7%) |
Mar 1994 | - | $600.00 K |
FAQ
- What is Nektar Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics annual total long term liabilities year-on-year change?
- What is Nektar Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly long term liabilities year-on-year change?
What is Nektar Therapeutics annual total long term liabilities?
The current annual total long term liabilities of NKTR is $215.78 M
What is the all time high annual total long term liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high annual total long term liabilities is $462.15 M
What is Nektar Therapeutics annual total long term liabilities year-on-year change?
Over the past year, NKTR annual total long term liabilities has changed by -$59.98 M (-21.75%)
What is Nektar Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of NKTR is $191.50 M
What is the all time high quarterly long term liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly total long term liabilities is $474.23 M
What is Nektar Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, NKTR quarterly total long term liabilities has changed by -$39.27 M (-17.02%)